首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1672102

全球血液篩檢市場研究報告 - 產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Blood Screening Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年03月01日 | 出版商:

Value Market Research | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球血液篩檢市場規模預計將從 2024 年的 34.5 億美元成長到 2033 年的 100.6 億美元，在 2026 年至 2033 年的預測期內呈現 12.62% 的強勁年複合成長率(CAGR)。

隨著傳染病的日益普及和安全輸血需求的不斷成長，血液篩檢市場將迎來大幅成長。血液篩檢是透過檢測病原體、抗體和其他有害物質來確保血液製品安全的關鍵過程。隨著醫療保健提供者優先考慮患者安全並且監管機構執行嚴格的測試要求，先進血液篩檢技術的採用預計會增加。這個市場正在見證向更有效率、更準確的檢測方法的轉變，包括核酸檢測（NAT）和多重檢測，這增強了血液篩檢過程的檢測能力。

此外，血液篩檢技術的進步正在推動市場創新。自動化系統和即時檢測解決方案的開發正在改變血液篩檢的方式，從而更快地獲得結果並提高工作流程效率。這些創新不僅提高了測試的準確性，而且減少了結果的周轉時間，使醫療保健提供者能夠及時就患者護理做出決策。隨著血液篩檢市場不斷發展，持續的研究和開發工作將在擴大可用的檢測解決方案範圍以滿足醫療保健提供者的多樣化需求方面發揮關鍵作用。

此外，人們對預防性醫療保健和早期檢測的日益重視正在改變血液篩檢格局。隨著人們對定期健康檢查重要性的認知不斷提高，患者更有可能尋求血液檢查，以便在病情惡化之前發現潛在的健康問題。醫療保健提供者也認知到主動篩檢在管理慢性病和改善患者預後的價值。隨著血液篩檢市場持續成長，技術進步、患者意識的提高和對預防保健的重視將在推動其未來成長方面發揮關鍵作用。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第 8 章：血液篩檢公司的競爭格局

血液篩檢市場競爭
夥伴關係/合作/協議
合併與收購
新產品發布
其他進展

第9章：公司簡介

頂級公司市佔率分析
市場集中度
Abbott

公司概況
公司收入
產品
最新動態

Danaher Corporation (Beckman Coulter)

公司概況
公司收入
產品
最新動態

Becton Dickinson And Company

公司概況
公司收入
產品
最新動態

Bio-Rad Laboratories Inc.

公司概況
公司收入
產品
最新動態

Hoffman-La Roche Ltd.

公司概況
公司收入
產品
最新動態

Grifols

公司概況
公司收入
產品
最新動態

公司概況
公司收入
產品
最新動態

Ortho-Clinical Diagnostics Inc.

公司概況
公司收入
產品
最新動態

Siemens Healthcare GmbH

公司概況
公司收入
產品
最新動態

Thermo Fisher Scientific Inc.

公司概況
公司收入
產品
最新動態

SOFINA SA (Biomerieux)

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

簡介目錄圖表

Product Code: VMR11210532

Global Blood Screening Market size is anticipated to grow from USD 3.45 Billion in 2024 to USD 10.06 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 12.62% during the forecast period of 2026 to 2033.

The blood screening market is poised for significant growth, driven by the increasing prevalence of infectious diseases and the rising demand for safe blood transfusions. Blood screening is a critical process that ensures the safety of blood products by detecting pathogens, antibodies, and other harmful substances. As healthcare providers prioritize patient safety and regulatory bodies enforce stringent testing requirements, the adoption of advanced blood screening technologies is expected to rise. This market is witnessing a shift towards more efficient and accurate testing methods, including nucleic acid testing (NAT) and multiplex assays, which enhance the detection capabilities of blood screening processes.

Moreover, advancements in blood screening technologies are propelling innovation within the market. The development of automated systems and point-of-care testing solutions is transforming the way blood screening is conducted, allowing for faster results and improved workflow efficiency. These innovations not only enhance the accuracy of testing but also reduce the turnaround time for results, enabling healthcare providers to make timely decisions regarding patient care. As the blood screening market continues to evolve, ongoing research and development efforts will play a crucial role in expanding the range of testing solutions available to meet the diverse needs of healthcare providers.

Additionally, the growing emphasis on preventive healthcare and early detection is shaping the blood screening landscape. As awareness of the importance of regular health screenings increases, patients are more likely to seek out blood tests that can identify potential health issues before they escalate. Healthcare providers are also recognizing the value of proactive screening in managing chronic conditions and improving patient outcomes. As the blood screening market continues to grow, the combination of technological advancements, increasing patient awareness, and a focus on preventive care will play a crucial role in driving its future growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Technology

Nucleic Acid Amplification Test (NAT)
ELISA
Chemiluminescence Immunoassay (CLIA & EIA )
Next Generation Sequencing (NGS)
Western Blotting (WB)

By Product

Reagent
Instrument
COMPANIES PROFILED
Abbott
Danaher Corporation (Beckman Coulter)
Becton Dickinson and Company
Bio-Rad Laboratories Inc.
Hoffman-La Roche Ltd.
Grifols
S.A.
Ortho-Clinical Diagnostics Inc.
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.
SOFINA SA (Biomerieux)
The above list can be customized.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. BLOOD SCREENING INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porters Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL BLOOD SCREENING MARKET ANALYSIS BY TECHNOLOGY

5.1. Overview By Technology
5.2. Historical and Forecast Data Analysis By Technology
5.3. Nucleic Acid Amplification Test (NAT) Historic and Forecast Sales By Regions
5.4. ELISA Historic and Forecast Sales By Regions
5.5. Chemiluminescence Immunoassay (CLIA & EIA ) Historic and Forecast Sales By Regions
5.6. Next Generation Sequencing (NGS) Historic and Forecast Sales By Regions
5.7. Western Blotting (WB) Historic and Forecast Sales By Regions

6. GLOBAL BLOOD SCREENING MARKET ANALYSIS BY PRODUCT

6.1. Overview By Product
6.2. Historical and Forecast Data Analysis By Product
6.3. Reagent Historic and Forecast Sales By Regions
6.4. Instrument Historic and Forecast Sales By Regions

7. GLOBAL BLOOD SCREENING MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE BLOOD SCREENING COMPANIES

8.1. Blood Screening Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF BLOOD SCREENING INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Abbott
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Danaher Corporation (Beckman Coulter)
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Becton Dickinson And Company
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Bio-Rad Laboratories Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Hoffman-La Roche Ltd.
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Grifols
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. S.A.
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Ortho-Clinical Diagnostics Inc.
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Siemens Healthcare GmbH
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Thermo Fisher Scientific Inc.
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments
9.13. SOFINA SA (Biomerieux)
- 9.13.1 Company Overview
- 9.13.2 Company Revenue
- 9.13.3 Products
- 9.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Technology (USD MN)
Nucleic Acid Amplification Test (NAT) Market Sales By Geography (USD MN)
ELISA Market Sales By Geography (USD MN)
Chemiluminescence Immunoassay (CLIA & EIA ) Market Sales By Geography (USD MN)
Next Generation Sequencing (NGS) Market Sales By Geography (USD MN)
Western Blotting (WB) Market Sales By Geography (USD MN)
Analysis By Product (USD MN)
Reagent Market Sales By Geography (USD MN)
Instrument Market Sales By Geography (USD MN)
Global Blood Screening Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Blood Screening Report
Market Research Process
Market Research Methodology
Global Blood Screening Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Technology
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Technology (USD MN)
Nucleic Acid Amplification Test (NAT) Market Sales By Geography (USD MN)
ELISA Market Sales By Geography (USD MN)
Chemiluminescence Immunoassay (CLIA & EIA ) Market Sales By Geography (USD MN)
Next Generation Sequencing (NGS) Market Sales By Geography (USD MN)
Western Blotting (WB) Market Sales By Geography (USD MN)
Global Market Analysis By Product (USD MN)
Reagent Market Sales By Geography (USD MN)
Instrument Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.